Subscribe to
this category


A total of 35 posts are filed under Finance
Eidos Therapeutics completes $64 Million Financing
Rare Daily Staff Eidos Therapeutics said it completed a $64 million Series B financing, which will be used to advance its oral therapeutic… Continue Reading
Homology Medicines Raises $144 Million in Upsized IPO
Rare Daily Staff Homology Medicines completed an upsized initial public offering at the top of its expected range to raise $144 million. The… Continue Reading
Flagship Pioneering Backs Foghorn Therapeutics with $50 Million to Develop New Class of Drugs to Regulate Genes
Rare Daily Staff Flagship Pioneering today said it made a $50 million commitment to Foghorn Therapeutics to discover and develop drugs based… Continue Reading
Generation Bio Raises $100 Million to Advance Re-Dosable Gene Therapy
Rare Daily Staff Generation Bio said it closed a $100 million series B financing to advance to the clinic its first two therapeutics… Continue Reading
Minoryx Therapeutics Spins Off See-Tx Platform to Create Gain Therapeutics
Rare Daily Staff Minoryx Therapeutics said it has spun off its Site-directed Enzyme Enhancement Therapy (SEE-Tx) platform to form Gain… Continue Reading
Tremeau Closes $5.2 Million Equity Round to Repurpose Vioxx for Rare Diseases
Rare Daily Staff Tremeau Pharmaceuticals said that it raised a total of $5.2 million in its first equity round to advance its pipeline of… Continue Reading
Gene Therapy Developer Avrobio Closes $60 Million Financing
Rare Daily Staff Gene therapy developer Avrobio said that it has completed a $60 million series B financing, which will be used to advance… Continue Reading
1 2 3 5

Follow us on Twitter